IMA ikenaoncology.com: Net earnings per share for the last 12 months

IMA (ImageneBio Inc) - company brandmark

Strict patent protection in the race for unique molecular results determines the success of ImageneBio Inc (IMA), which leads to a complete lack of pricing power due to the focus on trials. The change in the rolling net income per share clearly confirms this dependency, where -3.12 sets the current value of the metric. The development of precision therapy and oncology partnerships, which stimulate potential growth, complete the picture.

IMA Ikena Oncology, Inc. Earnings per share for the last 12 months (07/29/2025 - 11/12/2026)

Metric breakdowns and analytics for ImageneBio (IMA)

- current quotes and average value forecast:
Price Chart Ikena Oncology, Inc.|IMA - Consensus Target
- company stock capitalization data:
Market Valuation ImageneBio Inc|IMA - Enterprise Value
- balance sheet net asset value indicators:
Net Assets per Single Share Ikena Oncology|IMA - Accounting Capitalization|Market Capitalization to Book Value Ratio ikenaoncology.com|IMA - Company Assets
- debt level and financial liquidity data:
Total Debt to Capital ImageneBio Inc|IMA - Ratio of Long-Term Indebtedness to Capital|Short-Term Debt to Equity Ikena Oncology, Inc.|IMA - Company Total Debt|Debts to Book Capitalization ImageneBio Inc|IMA - Company Long-Term Debts|Company Short-Term Debts Ikena Oncology|Quick Ratio ikenaoncology.com
- earnings and multiples data:
IMA - Company Net Income|Expected Profit ImageneBio Inc|IMA - Price to Earnings Multiple|Forward P/E Multiple Ikena Oncology, Inc.|IMA - Price to Earnings Adjusted for Growth Rate|EV/EBITDA Multiple ImageneBio Inc|IMA - Profit before payment of interest, taxes and amortization|Net earnings per share (EPS TTM) Ikena Oncology|IMA - Net earnings per share for the last four quarters|Year-over-year earnings per share growth for the last twelve months ikenaoncology.com|IMA - Earnings per share growth rate in current year|Expected earnings per share growth for next year ImageneBio Inc
Initial company analysis:ikenaoncology.com (IMA)
Manufactured products of Ikena Oncology, Inc.

A stable operating environment in the US and the humanitarian status of ImageneBio Inc. developments minimize external risks. Analyzing the TTM earnings per share dynamics, an investor sees the total financial result of four quarters distributed across the entire volume of issuance. This metric measures the real efficiency of profit generation per unit of capital. Such an approach allows for an assessment of business scalability. This confirms the fundamental stability of the asset.

Competitors of ImageneBio Inc (IMA)

ARGX - Earnings per share for the last twelve months|biontech.de (BNTX) - Net earnings per share for the last 12 months|ABVX (Abivax Pharma) - Net earnings per share for the last 12 months|ADMA Biologics Inc (ADMA) - Net earnings per share (EPS TTM)|Earnings per share for the last twelve months Protagonist Therapeutics Inc|Earnings per share for the last 12 months IMVT (Immunovant Therapeutics)|Net earnings per share (EPS TTM) KNSA|GRFS - Net earnings per one share for the last twelve months|Net earnings per share (EPS TTM) ADPT (Adaptive Biotechnologies Corporation)|Net earnings per share for the last four quarters Celldex Therapeutics Inc (CLDX)|AUPH - Earnings per share for the last twelve months|BioCryst Corp (BCRX) - Net earnings per share for the last 12 months|VERA: Net earnings per share (EPS TTM)|dianthustx.com (DNTH) - Net earnings per share (EPS TTM)|PHVS (Pharvaris) - Net earnings per share (EPS TTM)|ABCL - Net earnings per share for the trailing year|Net earnings per share (EPS TTM) TRML|PGEN - Net earnings per one share for the last twelve months|Earnings per share for the last twelve months Pharming Group N.V. PHAR|NKTR: Earnings per share for the last 12 months|Upstream Bio - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Zenas Bio|IMNM: Net earnings per share (EPS TTM)|GOSS (Gossamer Bio Corp.) - Earnings per share for the last twelve months|KALV (KalVista Pharmaceuticals) - Net earnings per share (EPS TTM)|septerna.com (SEPN) - Net earnings per share for the last four quarters|Earnings per share for the last twelve months Pieris Pharmaceuticals, Inc. (PVLA)|SVRA - Net earnings per one share for the last twelve months|Rigel Pharmaceuticals Inc - Net earnings per share for the last 12 months|Earnings per share for the trailing year ANAB|Astria Therapeutics - Net earnings per share (EPS TTM)|Net earnings per share for the last four quarters engene.com ENGN|RAPT Therapeutics, Inc. (RAPT) - Earnings per share for the last twelve months|Earnings per share for the last 12 months JBIO|ACRS (Aclaris) - Net earnings per share (EPS TTM)|Net earnings per share for the last 12 months Kyverna Therapeutics, Inc (KYTX)|Net earnings per share (EPS TTM) TLSA|Net earnings per share for the last four quarters cabalettabio.com|Earnings per share for the last twelve months Ventyx Biosciences, Inc. VTYX|THTX - Net earnings per share for the last 12 months|Avalo Therapeutics Inc. - Net earnings per share (EPS TTM)|ELDN - Net earnings per share (EPS TTM)|Agenus (AGEN) - Earnings per share for the last twelve months|Earnings per one share for the last 12 months CLYM (climbbio.com)|ZURA (Zura Bio Limited) - Net earnings per share (EPS TTM)|ATYR: Earnings per share for the trailing year|Net earnings per share (EPS TTM) ADAG|Net earnings per share (EPS TTM) shattucklabs.com (STTK)|Earnings per share for the last twelve months Equillium EQ|Earnings per share for the trailing year CNTB|IMUX - Earnings per share for the last twelve months|Atara Biotherapeutics (ATRA) - Net earnings per share for the last 12 months|IFRX: Net earnings per share (EPS TTM)|X4 Pharmaceuticals, Inc (XFOR) - Net earnings per share (EPS TTM)|Net earnings per share for the last 12 months ACET|CELU: Earnings per share for the trailing year|Net earnings per share (EPS TTM) INMB|Net earnings per share for the last four quarters Barinthus Biotherapeutics PLC|Earnings per share for the last twelve months Kezar Life Sciences, Inc KZR|SABS - Net earnings per share for the last 12 months|AKTX - Earnings per share for the last twelve months|Enlivex Therapeutics (ENLV) - Net earnings per share for the last 12 months|QTTB (q32bio.com) - Net earnings per share for the last 12 months|GeoVax Labs (GOVX) - Net earnings per share (EPS TTM)|Earnings per share for the last twelve months Edesa|Earnings per share for the last 12 months IBIO (iBio Corporation)|Net earnings per share (EPS TTM) CARM|XTLB - Net earnings per one share for the last twelve months|Net earnings per share (EPS TTM) BOLT (Bolt Biotherapeutics, Inc.)|Net earnings per share for the last four quarters HCW Biologics, Inc. (HCWB)|APVO - Earnings per share for the last twelve months|AIM ImmunoTech, Inc. (AIM) - Net earnings per share for the last 12 months|ADTX: Net earnings per share (EPS TTM)|gribio.com (GRI) - Net earnings per share (EPS TTM)|XRTX (XORTX Therapeutics) - Net earnings per share (EPS TTM)|HIND - Net earnings per share for the trailing year|Net earnings per share (EPS TTM) REVB|INDP - Net earnings per one share for the last twelve months|Earnings per share for the last twelve months Scinai Immunotherapeutics SCNI|CALI: Earnings per share for the last 12 months|Affimed Therapeutics - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Allakos Inc.|HOOK: Net earnings per share (EPS TTM)|IGMS (IGM Biosciences) - Earnings per share for the last twelve months|ITOS (iTeos Therapeutics) - Net earnings per share (EPS TTM)|oceanbiomedical.com (OCEA) - Net earnings per share for the last four quarters|Earnings per share for the last twelve months TC BioPharm (TCBP)|THRD - Net earnings per one share for the last twelve months